TWi T211 25 mg Pill: clear white, capsule/oblong
The pill with imprint TWi T211 25 mg (Clear / White, Capsule/Oblong, 0mm) has been identified as Topiramate 25mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.
Images for TWi T211 25 mg
Topiramate
- Imprint
- TWi T211 25 mg
- Strength
- 25mg
- Color
- Clear / White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TWi Pharmaceuticals, Inc.
- Manufacturer
- Bora Pharmaceutical Laboratories Inc.
- National Drug Code (NDC)
- 24979-0211
See also:
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,340)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR, Topiragen
Professional resources
- Topiramate monograph
- Topiramate (FDA)
- Topiramate Capsules (FDA)
- Topiramate ER Capsules (FDA)
- Topiramate Oral Solution (FDA)
- Topiramate Tablets (FDA)
Other brands
Topamax, Trokendi XR, Eprontia, Qudexy XR
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.